News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
02 02 2023 Fourth quarter revenues of $2.33 billion, down 15.0% from 2021 Fourth quarter reported diluted earnings per share ("EPS") of $0.87, down 72.1% from 2021; and adjusted diluted EPS of $1.98, down...
-
01 23 2023 Quest Launches the First Annual "Know Your Health" Survey to Inspire Americans to Take Control of Their Well-being in 2023 SECAUCUS, N.J., Jan. 23, 2023 /PRNewswire/ -- The consumer-initiated...
-
01 17 2023 Marks 1-Year since Quest Diagnostics Announced Plans to Acquire Pack Health to Extend Digital Engagement and Coaching Services to Health Plans, Employers and Life Sciences Companies BIRMINGHAM, Ala.,
01 05 2023 Our Media Statement about COVID-19 Testing This is an evolving situation. Please check back to this page periodically for the latest information For more information, members of the media may...
-
12 12 2022 Analysis of 20 million clinical drug tests performed by Quest Diagnostics over the past decade shows increases in drug mixing and amphetamines use, and highlights the need for drug misuse...
-
12 01 2022 Quest Diagnostics (NYSE:DGX), the nation's leading provider of diagnostic information services, has been awarded a group purchasing agreement for its laboratory stewardship solution with Premier...
-
11 01 2022 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that Jim Davis has succeeded Steve Rusckowski as the CEO and President of Quest...
-
10 20 2022 Third quarter revenues of $2.49 billion, down 10.4% from 2021 Third quarter reported diluted earnings per share ("EPS") of $2.17, down 46.0% from 2021; and adjusted diluted EPS of $2.36, down...
10 13 2022 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced Jim Davis, CEO-Elect, has made several organizational changes and leadership...
-
10 11 2022 Analysis of more than 1.1 million test results across the United States suggests more people are living with undiagnosed cancer than before the pandemic, with potential for worse outcomes and...